Biopsy of Benign Liver Lesions: Risk Assessment and Clinical Approach

General Principles

• The American College of Radiology recommends that most benign liver lesions should not be biopsied because high-quality cross-sectional imaging provides sufficient diagnostic certainty without procedural risk 2, 4, 5, 6
• Biopsy of a benign liver lesion carries a small risk of needle-track tumor seeding and bleeding complications, making it generally unnecessary when imaging characteristics are diagnostic 1, 2

Specific Context

• In patients with suspected pancreatic cancer and liver lesions, biopsy of the liver metastasis is preferred over pancreatic biopsy due to higher accuracy and superior safety profile 1
• For resectable pancreatic disease with incidental liver lesion, do not biopsy if the liver lesion has benign imaging characteristics, and proceed with pancreatic resection 2, 4

Complications

• The risk of needle-track seeding for HCC is 0.1-0.7% 1, 2, 4
• The risk of needle-track seeding for metastatic pancreatic cancer is 2.7% with a median detection time of 17 months 3
• The risk of bleeding complications for hypervascular lesions is up to 9-12% 1

Technical Considerations

• The American College of Radiology recommends using ultrasound or CT guidance for biopsy, with technical success rates of 74-100% depending on modality 1
• The use of coaxial needle technique can minimize seeding risk 3
• Contrast-enhanced ultrasound (CEUS) guidance can achieve 88-96% success rates for lesions not visible on grayscale ultrasound 1